סרטיקן ® 0.25 מ"ג טבליות מסיסות

Kraj: Izrael

Język: hebrajski

Źródło: Ministry of Health

Składnik aktywny:

EVEROLIMUS 0.25 MG

Dostępny od:

NOVARTIS PHARMA SERVICES AG

Kod ATC:

L04AA18

Forma farmaceutyczna:

TABLETS DISPERSIBLE

Droga podania:

PER OS

Wyprodukowano przez:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Grupa terapeutyczna:

EVEROLIMUS

Wskazania:

Kidney and heart transplantationCertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. In kidney and heart transplantation, Certican should be used in combination with ciclosporin for microemulsion and corticosteroids.Liver transplantationCertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. In liver transplantation, Certican should be used in combination with tacrolimus and corticosteroids.

Data autoryzacji:

2010-02-01